Phase 2 Readout~quarter

Phase 2 Readout: relutrigine

Indication
SCN2A and SCN8A developmental and epileptic encephalopathies

Other upcoming events for PRAX

Phase 2 ReadoutPhase 2 Readout: elsunersen
PDUFA DatePDUFA Date: relutrigine
Phase 3 ReadoutPhase 3 Topline: Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Wi
PDUFA DatePDUFA Date: ulixacaltamide hcl
Phase 3 ReadoutPhase 3 Topline: A Phase 2,Double-Blind,Randomized Clinical Trial to Explore the Safety,Tolerability,Efficacy, and Ph

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: relutrigine — PRAX Phase 2 Readout | BioSniper